Emyria Ltd (ASX: EMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Emyria Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$25.66 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
366.63 million
Earnings per share
-0.018
Dividend per share
N/A
Year To Date Return
-57.33%
Earnings Yield
N/A
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Emyria Ltd (ASX: EMD)
Latest News
Healthcare Shares
ASX biotech share rockets 47% on 'landmark decision'
Cannabis Shares
Can ASX cannabis shares ever fully recover?
Cannabis Shares
Green shoots or just weeds? The outlook for ASX cannabis shares in FY23
Cannabis Shares
How did ASX cannabis shares perform in FY22?
Cannabis Shares
Remember when ASX cannabis shares were smoking hot? Where are they now?
Cannabis Shares
How have ASX cannabis shares been performing so far in 2022?
Share Gainers
These were the best-performing ASX cannabis shares in 2021
Share Market News
Would you like cheese with that? A look at some of Twiggy's highest profile ASX investments of 2021
Cannabis Shares
These were the top performing ASX cannabis shares in November
Healthcare Shares
3 ASX health care shares that burned the market today
Healthcare Shares
Here's why the Emyria (ASX:EMD) share price is up 17% to a record high
Healthcare Shares
Emyria (ASX:EMD) share price falling on news of MDMA therapy trial
1❯
EMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Emyria Ltd
Emyria Ltd operates a network of specialist medical clinics and uses purpose-built software and technology to gather clinical data from consenting patients. It operates in one segment of research and development.
EMD Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 04 Dec 2023 | $0.07 | $0.00 | 0.00% | 598,482 | $0.07 | $0.07 | $0.07 |
| 01 Dec 2023 | $0.07 | $0.00 | 0.00% | 20,000 | $0.07 | $0.07 | $0.07 |
| 30 Nov 2023 | $0.07 | $0.00 | 0.00% | 89,563 | $0.07 | $0.07 | $0.07 |
| 29 Nov 2023 | $0.07 | $0.00 | 0.00% | 290,272 | $0.07 | $0.07 | $0.07 |
| 28 Nov 2023 | $0.07 | $0.00 | 0.00% | 323,210 | $0.08 | $0.08 | $0.07 |
| 27 Nov 2023 | $0.08 | $0.00 | 0.00% | 286,824 | $0.08 | $0.08 | $0.07 |
| 24 Nov 2023 | $0.07 | $0.00 | 0.00% | 923,191 | $0.07 | $0.08 | $0.07 |
| 23 Nov 2023 | $0.07 | $0.00 | 0.00% | 247,767 | $0.07 | $0.07 | $0.07 |
| 22 Nov 2023 | $0.07 | $0.00 | 0.00% | 17,026 | $0.07 | $0.07 | $0.07 |
| 21 Nov 2023 | $0.07 | $0.00 | 0.00% | 175,311 | $0.07 | $0.07 | $0.07 |
| 20 Nov 2023 | $0.07 | $0.00 | 0.00% | 20,965 | $0.07 | $0.07 | $0.07 |
| 17 Nov 2023 | $0.07 | $0.00 | 0.00% | 258,031 | $0.07 | $0.07 | $0.07 |
| 16 Nov 2023 | $0.08 | $0.00 | 0.00% | 582 | $0.08 | $0.08 | $0.08 |
| 15 Nov 2023 | $0.08 | $0.00 | 0.00% | 37,553 | $0.08 | $0.08 | $0.08 |
| 14 Nov 2023 | $0.07 | $0.00 | 0.00% | 143,668 | $0.08 | $0.08 | $0.07 |
| 13 Nov 2023 | $0.07 | $-0.01 | -12.35% | 476,286 | $0.08 | $0.08 | $0.07 |
| 10 Nov 2023 | $0.08 | $0.00 | 0.00% | 159,826 | $0.08 | $0.08 | $0.08 |
| 09 Nov 2023 | $0.08 | $0.00 | 0.00% | 20,000 | $0.08 | $0.08 | $0.08 |
| 08 Nov 2023 | $0.08 | $0.00 | 0.00% | 139,490 | $0.08 | $0.08 | $0.08 |
| 07 Nov 2023 | $0.08 | $0.00 | 0.00% | 457,727 | $0.08 | $0.09 | $0.08 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 09 Oct 2023 | Alistair Vickery | Buy | 32,456 | $2,255 |
On-market trade.
|
| 05 Oct 2023 | Stewart Washer | Issued | 666,666 | $45,999 |
Rights issue. As per announcement on 10-10-2023
|
| 05 Oct 2023 | Stewart Washer | Issued | 1,333,333 | $99,999 |
Rights issue.
|
| 05 Oct 2023 | Michael Winlo | Issued | 64,297 | $4,822 |
Rights issue.
|
| 05 Oct 2023 | Michael Winlo | Issued | 32,148 | $2,218 |
Rights issue. As per announcement on 10-10-2023
|
| 05 Oct 2023 | Alistair Vickery | Issued | 18,519 | $1,388 |
Rights issue.
|
| 05 Oct 2023 | Alistair Vickery | Issued | 32,456 | $2,434 |
Rights issue.
|
| 05 Oct 2023 | Alistair Vickery | Issued | 25,488 | $1,758 |
Rights issue. As per announcement on 10-10-2023
|
| 09 Aug 2023 | Stewart Washer | Buy | 225,000 | $21,240 |
On-market trade.
|
| 09 Aug 2023 | Alistair Vickery | Buy | 115,418 | $10,849 |
On-market trade. http://www.aspecthuntley.com.au/asxdata/20231010/pdf/02723469.pdf
|
| 08 Aug 2023 | Michael Winlo | Buy | 200,000 | $19,200 |
On-market trade.
|
| 23 Feb 2023 | Alistair Vickery | Issued | 69,444 | $15,624 |
Placement.
|
| 23 Feb 2023 | Alistair Vickery | Issued | 138,889 | $25,000 |
Placement.
|
| 23 Feb 2023 | Michael Winlo | Issued | 111,111 | $24,999 |
Placement.
|
| 23 Feb 2023 | Michael Winlo | Issued | 222,222 | $39,999 |
Placement.
|
| 23 Feb 2023 | Matthew (Matt) Callahan | Issued | 55,556 | $10,000 |
Placement.
|
| 23 Feb 2023 | Matthew (Matt) Callahan | Issued | 27,778 | $6,250 |
Placement.
|
| 23 Feb 2023 | Stewart Washer | Issued | 166,667 | $37,500 |
Placement.
|
| 23 Feb 2023 | Stewart Washer | Issued | 333,333 | $59,999 |
Placement.
|
| 23 Feb 2023 | Karen Smith | Issued | 83,333 | $14,999 |
Placement.
|
| 23 Feb 2023 | Karen Smith | Issued | 41,667 | $9,375 |
Placement.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Sir John Tooke | Non-Executive Director | Feb 2020 |
Sir Tooke is Executive Chairman of Academic Health Solutions, a start-up Group offering advice to clients internationally on medical research and health service transformation. He is Senior Independent Director at BUPA Chile and was until 2019 non-executive director of the BUPA main Board and the Chair of the Medical Advisory Council. Mr Tooke is also a member of Risk Committee.
|
| Dr Michael Winlo | Managing Director | Nov 2019 |
Dr Winlo was CEO at Linear Clinical Research Ltd (Linear) until October 2019, a company that provides clinical trial services for US and Asia-based biotech companies. Linear adopt electronic data capture technology. Dr Winlo retains a Directorship at Linear.
|
| Dr Karen Smith | Non-Executive Director | Nov 2021 |
Dr Smith has overseen more than 100 clinical trials and more than 20 regulatory approvals leading to product launches across diverse therapeutic areas including neuroscience, rare disease, oncology, cardiology, dermatology, oncology and anti-infectives. In addition to R&D and pipeline development, her experience includes the acquisition of U.S. and international companies, divestitures and negotiating partnership deals between biotech and pharma. Dr Smith was recently Chief Medical Officer of Emergent BioSolutions.
|
| Dr Mohit Kaushal | Non-Executive Director | Aug 2023 |
Dr KaushaL has also been appointed to the FDASIA Workgroup of the Health IT Policy Committee and to the National Committee on Vital and Health Statistics, advising HHS on Data Access and Use.
|
| Mr Greg Hutchinson | Non-Executive Director | Nov 2023 |
--
|
| Ms Susan Patricia Park | Company Secretary | Mar 2023 |
-
|
| Susan Patricia Park | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Dr Stewart James Washer & Dr Patrizia Derna Washer <The Washer Family A/C> | 29,950,599 | 9.71% |
| HSBC Custody Nominees (Australia) Limited | 24,157,615 | 7.83% |
| Mr Craig Lawrence Darby <Craig Lawrence Darby A/C> | 21,109,790 | 6.85% |
| Mal Washer Nominees Pty Ltd <Mal Washer Nominees Pty Ltd> | 19,600,000 | 6.36% |
| Mercator Shipwrights Pty Ltd <Mecator A/C> | 19,600,000 | 6.36% |
| Mr Sufian Ahmad <Sixty Two Capital A/C> | 15,831,766 | 5.13% |
| Mr Pak Lim Kong | 6,766,667 | 2.19% |
| Kobala Investments Pty Ltd <Fernando Edward Family A/C> | 5,731,960 | 2.08% |
| Mr Stephen Peter Somerville | 4,900,000 | 1.59% |
| Mr Bilal Ahmad | 3,500,000 | 1.14% |
| Citicorp Nominees Pty Limited | 2,872,392 | 0.93% |
| Lakewest Pty Ltd <Raymond Desmond Family A/C> | 2,190,000 | 0.71% |
| Mr Hakan Sahin &Mr Gursel Daniskan <Strategic Super A/C> | 2,190,000 | 0.71% |
| Mr Steve John Benrnard Grimley | 2,166,304 | 0.70% |
| Woodlands Opportunity Fund Pty Ltd | 2,031,221 | 0.66% |
| D Schecter Medicine Professional Corporation | 1,960,000 | 0.64% |
| Adam James <Araucaria A/C> | 1,960,000 | 0.64% |
| Miss Sihong Zeng | 1,821,376 | 0.59% |
| Canopy Growth Corporation | 1,562,500 | 0.51% |
| Mr Ahmed Noman | 1,560,847 | 0.51% |
| Mr Fadi Diab | 1,552,941 | 0.50% |
| Mr Dean Brett Blankfield | 1,540,177 | 0.50% |
